Life Sciences Industry: Key Trends and Developments for Asia-Based Investors

With the consequences of the global pandemic still reverberating throughout the Asia-Pacific region, governments and businesses in the area continue to focus on the life sciences industry. From startups to global multinational companies, there is a broad acknowledgment that with consumer demand and growth potential, there are significant opportunities for dealmaking and investments.

In this compilation of key takeaways from Morgan Lewis’s Asia Life Sciences Webinar Series, we review hot topics and key updates in the life sciences industry for those operating in Asia, both looking to invest in and outside of the regions, including the impact of US-China relations, trends for the startup community, and what to know about outbound investment from Asia.